Applied Therapeutics, Inc. — Director's Dealing 2023

Jan 13, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Applied Therapeutics Inc. (APLT)
CIK: 0001697532
Period of Report: 2023-01-11

Reporting Person: Shendelman Shoshana (Director, President and CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-01-11	Common Stock	S	15870	$0.91	Disposed	751625	Direct
2023-01-11	Common Stock	A	1964362	$0.00	Acquired	2715987	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1750000	Indirect
Common Stock	1492094	Indirect
Common Stock	709720	Indirect
Common Stock	290280	Indirect
Common Stock	88397	Indirect

Footnotes

F1: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of compensatory Restricted Stock Units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.

F2: Includes 1,725,000 compensatory Restricted Stock Units granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. Each compensatory Restricted Stock Unit represents a contingent right to receive one share of the issuer's common stock. One-fourth (1/4th) of the compensatory Restricted Stock Units shall vest on January 11, 2024, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory Restricted Stock Units shall vest each month thereafter, subject to the reporting person continuing to provide services through each such date.

F3: Includes 239,362 compensatory Restricted Stock Units granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. The issuer determined to make this compensatory grant of Restricted Stock Units to the reporting person in lieu of a cash bonus that otherwise would have been paid with respect to 2022. All of the shares subject to the compensatory Restricted Stock Units vested immediately upon grant.

F4: Through a grantor retained annuity trust.

F5: Through a family trust controlled by the reporting person's spouse.

F6: Through the reporting person's spouse.

F7: Through a family trust controlled by the reporting person.

F8: Through Clearpoint Strategy Group LLC of which the reporting person is the sole owner.